ARCHIVES

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

This article is from The Cancer Letter archive.

Vol. 34 No. 42 | November 14, 2008

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

DC Board Okay One Recompetition, Disapproves Two

November 12, 1982

Interview: Extramural Programs Need Coordination, Klausner Says

July 25, 1997

Panel Calls For New Office, Advisory Groups To Oversee NCI’s Translational Research.

June 22, 2007

A Provision Of The EARLY Bill Is Inserted Into House Appropriations For Labor, HHS

July 24, 2009

Clearinghouse Finds Seven Compounds Are Carcinogenic, Human Threat

September 1, 1978